BSD Medical Corporation to Host Investor Conference Call on January 17, 2012

BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD), a leading provider of medical systems that utilize targeted heat therapy to treat cancer, will host an Investor Conference Call with live webcast on Tuesday, January 17, 2012, at 2:00 p.m. Eastern time/12:00 p.m. Mountain time. Officers of the Company will discuss recent developments and strategic plans for 2012.

Individuals interested in participating in the conference call may do so by visiting the Investor Relations section of the Company's web site at www.BSDMedical.com or by dialing 877-941-6009 from the United States, or 480-629-9645 from outside the United States, and referencing conference ID 4499888. We request that you RSVP for the conference call by emailing aomalley@finprofiles.com before 4:00 p.m. Eastern time on Friday, January 13, 2012.

A telephone replay will be available through January 24, 2012, by dialing 800-406-7325 from the United States, or 303-590-3030 from outside the United States, and entering conference ID 4499888. A webcast replay will be available for 90 days.

About BSD Medical Corporation

BSD Medical Corporation develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused radiofrequency (RF) and microwave energy. BSD's product lines include both hyperthermia and ablation treatment systems. BSD's hyperthermia cancer treatment systems, which have been in use for many years in the United States, Europe and Asia, are used to treat certain tumors with heat (hyperthermia) while increasing the effectiveness of other therapies such as radiation therapy. BSD's microwave ablation system has been developed as a stand-alone therapy to ablate and destroy soft tissue. The Company has developed extensive intellectual property, multiple products in the market and established distribution in the United States, Europe and Asia. Certain of the Company's products have received regulatory approvals in the United States, Europe and China. For further information visit BSD Medical's web site at www.BSDMedical.com.

Statements contained in this press release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date.